The Role of the Advanced Practitioner in Maintaining Adherence in Patients on Oral Oncolytics

Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

This CME/CE/CPE accredited supplement is jointly provided by:

HSME NewlogoHSME Newlogo

JADPRO 5 Fig02

JADPRO 5 Fig03

Faculty

Diane Cope, PhD, ARNP-BC, AOCNP®, Florida Cancer Specialists and Research Institute 

Kimberly M. Hicks, PharmD, MHA, HHCS Health Group of Companies

John Novak, CHA, PA-C, Rocky Mountain Cancer Centers and University of Colorado School of Medicine

Susan Scherer, RN, BSN, OCN®, RN Cancer Guides Solutions 

This activity is supported by unrestricted educational grants from AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Novartis Pharmaceutical Corporation; and Taiho Oncology, Inc.


Editorial

A Letter From The Guest Editor



Read More
Review Article

The Role of the Advanced Practitioner in Maintaining Adherence in Patients on Oral Oncolytics

Kimberly M. Hicks,(1) PharmD, MHA, Diane Cope,(2) PhD, ARNP-BC, AOCNP®, John Novak,(3) CHA, PA-C, and Susan Scherer,(4) RN, BSN, OCN

Read More
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.